# Canopy Growth Corp: filings

CGC · Nasdaq · CIK 1737927 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/cgc.md) · [Financials](/companies/cgc/financials.md) · [Filings](/companies/cgc/filings.md) · [Insiders](/companies/cgc/insiders.md)

## Reports and events: 366 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (6-K 189, 4 161, 8-K 119, DEFA14A 55, 424B3 44, 3 22, 10-Q 19, UPLOAD 15, CORRESP 14, SC 13D/A 13, EFFECT 12, DEF 14A 8, 10-K 7, 424B7 7, PRER14A 6, SD 6, 4/A 5, POS AM 5, PRE 14A 5, S-1 5, 424B5 4, ARS 4, S-8 4, 3/A 3, CERT 3, S-3ASR 3, 40-F 2, 8-K/A 2, S-3 2, 10-K/A 1, 25 1, 25/A 1, 40FR12B 1, 6-K/A 1, 8-A12B 1, 8-A12B/A 1, F-X 1, NT 10-K 1, NT 10-K/A 1, POSASR 1, SC 13D 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 17:19 ET | [8-K](/filings/0001104659-26-118521.md) | 5.07 Shareholder vote results | 0001104659-26-118521 |
| 2026-10-16 | 21:00 ET | [8-K](/filings/0001104659-26-116639.md) | 3.01 Delisting notice | 0001104659-26-116639 |
| 2026-08-07 | 20:50 ET | [DEF 14A](/filings/0001104659-26-092759.md) | Proxy statement, period 2026-09-25 | 0001104659-26-092759 |
| 2026-08-07 | 20:05 ET | [8-K](/filings/0001104659-26-092687.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-26-092687 |
| 2026-08-07 | 11:05 ET | [8-K](/filings/0001193125-26-339131.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-339131 |
| 2026-08-07 | 10:45 ET | [10-Q](/filings/0001193125-26-339076.md) | Quarterly report, period 2026-06-30 | 0001193125-26-339076 |
| 2026-06-15 | 11:06 ET | [8-K](/filings/0001193125-26-270277.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-270277 |
| 2026-06-15 | 10:46 ET | [10-K](/filings/0001193125-26-270260.md) | Annual report, period 2026-03-31 | 0001193125-26-270260 |
| 2026-05-27 | 20:16 ET | [8-K](/filings/0001104659-26-066964.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-066964 |
| 2026-05-15 | 21:06 ET | [8-K](/filings/0001104659-26-062784.md) | 4.02 Non-reliance on financial statements; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-062784 |
| 2026-03-16 | 11:59 ET | [8-K](/filings/0001104659-26-028015.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-028015 |
| 2026-02-06 | 12:05 ET | [8-K](/filings/0001193125-26-040294.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-040294 |
| 2026-02-06 | 11:45 ET | [10-Q](/filings/0001193125-26-040275.md) | Quarterly report, period 2025-12-31 | 0001193125-26-040275 |
| 2026-01-08 | 21:15 ET | [8-K](/filings/0001104659-26-002134.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-002134 |
| 2025-12-15 | 12:15 ET | [8-K](/filings/0001104659-25-120861.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-120861 |
| 2025-11-07 | 12:05 ET | [8-K](/filings/0001193125-25-270995.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-270995 |
| 2025-11-07 | 11:45 ET | [10-Q](/filings/0001193125-25-270960.md) | Quarterly report, period 2025-09-30 | 0001193125-25-270960 |
| 2025-10-14 | 10:06 ET | [8-K](/filings/0001104659-25-098884.md) | 5.07 Shareholder vote results | 0001104659-25-098884 |
| 2025-09-17 | 20:35 ET | [8-K](/filings/0001104659-25-090861.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-090861 |
| 2025-08-29 | 21:03 ET | [8-K](/filings/0001104659-25-085779.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-085779 |
| 2025-08-08 | 11:06 ET | [8-K](/filings/0001193125-25-176020.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-176020 |
| 2025-08-08 | 10:45 ET | [10-Q](/filings/0001193125-25-175982.md) | Quarterly report, period 2025-06-30 | 0001193125-25-175982 |
| 2025-08-07 | 20:29 ET | [DEF 14A](/filings/0001104659-25-075215.md) | Proxy statement, period 2025-09-26 | 0001104659-25-075215 |
| 2025-07-29 | 21:03 ET | [8-K](/filings/0001104659-25-071781.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-071781 |
| 2025-07-09 | 13:03 ET | [8-K](/filings/0001104659-25-066600.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-066600 |
| 2025-05-30 | 11:19 ET | [8-K](/filings/0000950170-25-079321.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-079321 |
| 2025-05-30 | 10:45 ET | [10-K](/filings/0000950170-25-079317.md) | Annual report, period 2025-03-31 | 0000950170-25-079317 |
| 2025-04-01 | 11:54 ET | [8-K](/filings/0001104659-25-030245.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-030245 |
| 2025-02-28 | 22:19 ET | [8-K](/filings/0001104659-25-019244.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-019244 |
| 2025-02-07 | 12:06 ET | [8-K](/filings/0000950170-25-015847.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-015847 |
| 2025-02-07 | 11:45 ET | [10-Q](/filings/0000950170-25-015839.md) | Quarterly report, period 2024-12-31 | 0000950170-25-015839 |
| 2024-12-10 | 21:42 ET | [8-K](/filings/0001104659-24-127226.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-127226 |
| 2024-12-09 | 21:15 ET | [8-K](/filings/0001104659-24-126760.md) | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-126760 |
| 2024-11-26 | 21:15 ET | [8-K](/filings/0001104659-24-123094.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-123094 |
| 2024-11-08 | 12:10 ET | [8-K](/filings/0000950170-24-123682.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123682 |
| 2024-11-08 | 11:45 ET | [10-Q](/filings/0000950170-24-123672.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123672 |
| 2024-10-17 | 11:56 ET | [8-K](/filings/0001104659-24-109376.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-109376 |
| 2024-09-25 | 12:41 ET | [8-K](/filings/0001104659-24-102623.md) | 5.07 Shareholder vote results | 0001104659-24-102623 |
| 2024-08-23 | 20:16 ET | [8-K](/filings/0001104659-24-092438.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-092438 |
| 2024-08-16 | 12:53 ET | [8-K](/filings/0001104659-24-090360.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-090360 |
| 2024-08-09 | 11:22 ET | [8-K](/filings/0000950170-24-094343.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-094343 |
| 2024-08-09 | 10:30 ET | [10-Q](/filings/0000950170-24-094330.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094330 |
| 2024-08-01 | 13:03 ET | [DEF 14A](/filings/0001104659-24-084685.md) | Proxy statement, period 2024-09-24 | 0001104659-24-084685 |
| 2024-06-06 | 12:31 ET | [8-K](/filings/0001104659-24-068924.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-068924 |
| 2024-06-05 | 20:28 ET | [8-K](/filings/0001104659-24-068696.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-068696 |
| 2024-06-05 | 11:00 ET | [8-K](/filings/0001104659-24-068499.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-068499 |
| 2024-05-30 | 11:09 ET | [8-K](/filings/0000950170-24-066246.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-066246 |
| 2024-05-30 | 10:46 ET | [10-K](/filings/0000950170-24-066240.md) | Annual report, period 2024-03-31 | 0000950170-24-066240 |
| 2024-05-13 | 20:26 ET | [8-K](/filings/0001104659-24-060572.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-060572 |
| 2024-05-07 | 20:10 ET | [S-1](/filings/0001104659-24-058001.md) | Registration statement | 0001104659-24-058001 |

Page 1 of 8. [Older](/companies/cgc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.